Article
LMWHs and DOACs Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin
2026-03-24
Abstract excerpt
<h4>Background: </h4> /Objectives: Tissue factor (TF)-expressing cancer cells and their extracellular vesicles (CaCe-dEVs) are key drivers of cancer-associated hypercoagulability and vascular dysfunction. While low-molecular-weight heparins (LMWHs) and direct FXa inhibitors are standard therapies for cancer-associated thrombosis, their direct effects on cancer cell procoagulant potential and endothelial responses...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e3dd95c8-7337-5ce5-8fc3-01ef46f92764
- DOI
- 10.20944/preprints202603.1869.v1
